ALEXIS MAHAFFEY: Open Payments
NPI 1902550825 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,761 in 66 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $15 · 2025 $1,761
Food & beverage: $1,726Education: $35
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $469 |
| GENZYME CORPORATION | 10 | $295 |
| Insmed, Inc. | 8 | $208 |
| Amgen Inc. | 5 | $118 |
| Regeneron Healthcare Solutions, Inc. | 4 | $100 |
| Viatris Specialty LLC | 4 | $85 |
| GlaxoSmithKline, LLC. | 4 | $85 |
| Grifols USA, LLC | 2 | $69 |
| Mallinckrodt Hospital Products Inc. | 3 | $69 |
| HARMONY BIOSCIENCES LLC | 2 | $61 |
Products named: DUPIXENT, TEZSPIRE, Arikayce, FASENRA, YUPELRI, Prolastin-C Liquid, ACTHAR, NUCALA.
Industry payments across AL — which companies pay providers there.
